MANNITOL 20 % IMUNA SOLUTION FOR INFUSION
Pajjiż: Iżrael
Lingwa: Ingliż
Sors: Ministry of Health
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
MANNITOL
Disponibbli minn:
A.L. MEDI-MARKET LTD.
Kodiċi ATC:
B05BC01
Għamla farmaċewtika:
SOLUTION FOR INFUSION
Kompożizzjoni:
MANNITOL 200 G / 1000 ML
Rotta amministrattiva:
I.V
Tip ta 'preskrizzjoni:
Required
Manifatturat minn:
IMUNA PHARM A.S, SLOVAK REPUBLIC
Żona terapewtika:
MANNITOL
Indikazzjonijiet terapewtiċi:
Mannitol 20% Imuna, Solution for Infusion is indicated for: - The promotion of diuresis, in the prevention and/or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established;- The reduction of intracranial pressure and treatment of cerebral edema by reducing brain mass; - The reduction of elevated intraocular pressure when the pressure cannot be lowered by other means, and promoting the urinary excretion of toxic substances.
Data ta 'l-awtorizzazzjoni:
2022-12-22
